Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Troxerutin and Poreine Cerebroside Injection for Acute Ischemic Stroke
ChiCTR2000039862Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of troxerutin + porcine cerebroside in ischemic stroke (2 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Change in NIHSS score after 10 days of treatment. Started Nov 2020; status: recruiting.
02
Drugs
troxerutin + porcine cerebroside
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000039862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039862.